My guess is that Zenith's success has a lot to do with the work of Sanjay Lakhotia. He seems to be the only one involved in either company who has a real biotech business track record and credibility. The rest of the business management in the two companies seem only to be able to hang onto the coat tails of the science and hope something good comes along.